Actively Recruiting
Interleukin23 in Systemic Lupus
Led by Sohag University · Updated on 2024-12-03
90
Participants Needed
2
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
assement of interleukin 23 in serum of patients with systemic lupus erythematosus related interstial lung disease .
CONDITIONS
Official Title
Interleukin23 in Systemic Lupus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with systemic lupus erythematosus
- Patients with systemic lupus erythematosus with interstitial lung disease
You will not qualify if you...
- Patients with chest conditions other than interstitial lung disease
- Patients receiving biological blocking antibodies
- Patients treated with immunosuppressive drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Sohag university hospital
Sohag, Egypt
Actively Recruiting
2
Sohag university
Sohag, Egypt
Actively Recruiting
Research Team
K
Khadiga M Salem, resident doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
DIAGNOSTIC
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here